PLAU
The PLAU Gene: A Key Player in Inflammation and Disease
Description
The PLAU gene encodes the urokinase plasminogen activator (uPA), a serine protease that plays a crucial role in various physiological processes, including:
- Inflammation: uPA cleaves plasminogen to form plasmin, which breaks down fibrin, a protein involved in blood clotting and immune responses.
- Tissue remodeling: Plasmin can degrade extracellular matrix (ECM) proteins, facilitating tissue remodeling during wound healing, angiogenesis (new blood vessel formation), and organ development.
- Cell migration: uPA can promote cell movement by activating integrins, receptors that allow cells to bind to ECM proteins.
Associated Diseases
Dysregulation of PLAU expression and function has been associated with a wide range of diseases, including:
- Cancer: uPA is overexpressed in many types of cancer, where it promotes tumor growth, invasion, and metastasis by enhancing cell proliferation, angiogenesis, and ECM remodeling.
- Arthritis: Elevated PLAU levels have been found in rheumatoid arthritis and osteoarthritis, where they contribute to inflammation and cartilage destruction.
- Vascular diseases: Abnormal uPA activity has been linked to atherosclerosis, thrombosis, and aneurysm formation.
- Neurodegenerative diseases: Impaired PLAU function has been implicated in Alzheimer's disease and Parkinson's disease, where it may affect neuronal survival and synaptic plasticity.
Did you Know ?
According to the National Cancer Institute, high PLAU expression is observed in approximately 70% of human cancers, making it a potential target for cancer therapy.
